Indaptus Therapeutics, Inc. (NASDAQ:INDP) Sees Significant Drop in Short Interest
Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 58,200 shares, a decrease of 25.9% from the February 13th total of 78,500 shares. Currently, 0.5% of the company’s shares are sold short. […]
Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 58,200 shares, a decrease of 25.9% from the February 13th total of 78,500 shares. Currently, 0.5% of the company’s shares are sold short. […]
-logo.png?v=20230920074015&w=240&h=240&zc=2){kind=logo}
